Cargando…

Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy

Aplastic anemia is a rare blood disease characterized by the destruction of the hematopoietic stem cells (HSC) in the bone marrow that, in the majority of cases, is caused by an autoimmune reaction. Patients with aplastic anemia are treated with immunosuppressive drugs and some of them, especially y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Hiroaki, Rai, Shinya, Tanaka, Hirokazu, Espinoza, J. Luis, Komori-Inoue, Maiko, Kakutani, Hiroaki, Minamoto, Shuji, Kumode, Takahiro, Nakayama, Shoko, Taniguchi, Yasuhiro, Morita, Yasuyoshi, Okuda, Takeshi, Tatsumi, Yoichi, Ashida, Takashi, Matsumura, Itaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232501/ https://www.ncbi.nlm.nih.gov/pubmed/32276450 http://dx.doi.org/10.3390/v12040416

Ejemplares similares

Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
por: Kumode, Takahiro, et al.
Publicado: (2020)

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
por: Rai, Shinya, et al.
Publicado: (2018)

Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma
por: Haeno, Takahiro, et al.
Publicado: (2023)

Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia
por: Miyatake, Junichi, et al.
Publicado: (2018)

Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma
por: Rai, Shinya, et al.
Publicado: (2021)

The Impact of Hemodialysis and Liver Cirrhosis on the Plasma Concentrations of Tyrosine Kinase Inhibitors in a Patient with Chronic Myeloid Leukemia
por: Taniguchi, Yasuhiro, et al.
Publicado: (2020)

Immunemodulatory Effects of 5-Azacitidin Through Expansion of Functional Regulatory T Cells on Paraneoplastic Inflammation Associated With Myelodysplastic Syndromes: A Case Report
por: Serizawa, Kentaro, et al.
Publicado: (2018)

Potent efficacy of chlorpromazine in acute myeloid leukemia harboring KIT-D816V mutation
por: Rai, Shinya, et al.
Publicado: (2021)

Excessive Reactive Iron Impairs Hematopoiesis by Affecting Both Immature Hematopoietic Cells and Stromal Cells
por: Tanaka, Hirokazu, et al.
Publicado: (2019)

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders
por: Sawada, Akihisa, et al.
Publicado: (2018)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019)

Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders
por: Kakiuchi, Seiji, et al.
Publicado: (2020)

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
por: Mukai, Takeo, et al.
Publicado: (2023)

Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic IL2RG Mutation
por: Tanita, Kay, et al.
Publicado: (2019)

Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
por: Chappuis, B B, et al.
Publicado: (1990)

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
por: Cai, Qingqing, et al.
Publicado: (2015)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
por: Kim, Wook Youn, et al.
Publicado: (2019)

Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V
por: Rai, Shinya, et al.
Publicado: (2020)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Association of Epstein-Barr virus with an angioimmunoblastic lymphadenopathy-like lymphoproliferative syndrome.
por: White, A. C., et al.
Publicado: (1989)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
por: Ban, Yumiko, et al.
Publicado: (2020)

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
por: Barros, Mario Henrique M., et al.
Publicado: (2023)

Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease
por: Sankararaman, Senthilkumar, et al.
Publicado: (2014)

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target
por: Tse, Eric, et al.
Publicado: (2015)

Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases
por: Latour, Sylvain, et al.
Publicado: (2018)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
por: Crombie, Jennifer L., et al.
Publicado: (2019)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
por: Ai, Junhong, et al.
Publicado: (2018)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
por: Ishikawa, Eri, et al.
Publicado: (2021)

Development of Epstein–Barr virus-associated lymphoproliferative disorder and hemophagocytic lymphohistiocytosis during long-term lenalidomide maintenance therapy in multiple myeloma
por: Yoshida, Mina, et al.
Publicado: (2022)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features
por: Kawamoto, Keisuke, et al.
Publicado: (2018)

Overexpression of Activation-Induced Cytidine Deaminase in MTX- and Age-Related Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders of the Head and Neck
por: Kikuchi, Kentaro, et al.
Publicado: (2015)

Chronic Epstein-Barr virus infection causing both benign and malignant lymphoproliferative disorders
por: Kwun, Yoojin, et al.
Publicado: (2014)

Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases
por: Yachie, Akihiro
Publicado: (2018)

Epstein-Barr Virus–Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment
por: Shahid, Sanam, et al.
Publicado: (2021)

The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers
por: Biggi, Alison Felipe Bordini, et al.
Publicado: (2022)

Hedgehog Signaling Components Are Expressed in Choroidal Neovascularization in Laser-induced Retinal Lesion
por: Nochioka, Katsunori, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hebgp1pd5pskqubgdbpshe8r8b